These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE; Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304 [TBL] [Abstract][Full Text] [Related]
3. Tibolone. Reynir Tomas G Acta Obstet Gynecol Scand; 2004 Jun; 83(6):606. PubMed ID: 15144349 [No Abstract] [Full Text] [Related]
4. A case report of recurrent endometriosis following Tibolone hormone replacement therapy. Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209 [No Abstract] [Full Text] [Related]
5. Tibolone and breast cancer risk: effects of selection bias cannot be eliminated in observational studies. Coomarasamy A BJOG; 2008 Jun; 115(7):919. PubMed ID: 18485174 [No Abstract] [Full Text] [Related]
6. The LIBERATE tibolone trial in breast cancer survivors. Speroff L Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923 [No Abstract] [Full Text] [Related]
7. By the way, doctor. What happened to tibolone--the estrogen alternative we heard about a while ago? Did it turn out not to be effective? Robb-Nicholson C Harv Womens Health Watch; 2004 Apr; 11(8):8. PubMed ID: 15100062 [No Abstract] [Full Text] [Related]
8. Carcinoma of the endometrium in patients treated with tibolone. Yazigi R; Sahid S; Contreras L; Rodriguez T Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984 [TBL] [Abstract][Full Text] [Related]
9. [Tibolone-induced hepatotoxicity]. Blanco Sampascual S; de Las Heras Niño B; Cabezudo Gil P; Ruiz Eguiluz P; Orive Cura V Gastroenterol Hepatol; 2002 Apr; 25(4):274. PubMed ID: 11975880 [No Abstract] [Full Text] [Related]
10. What have we really learned from 'LIBERATE' trial? Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777 [TBL] [Abstract][Full Text] [Related]
11. Tibolone revisited: still a good treatment option for healthy, early postmenopausal women. Kenemans P Gynecol Endocrinol; 2010 Apr; 26(4):237-9. PubMed ID: 20017707 [No Abstract] [Full Text] [Related]
12. Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke. de Melo NR; Pompei LM Gynecol Endocrinol; 2010 Feb; 26(2):73-5. PubMed ID: 19995151 [No Abstract] [Full Text] [Related]
13. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Campisi R; Marengo FD Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936 [TBL] [Abstract][Full Text] [Related]
14. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth]. Carranza Lira S Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511 [TBL] [Abstract][Full Text] [Related]